A simple blood test for colon cancer

Nov 20, 2008

People are often reluctant to undergo a routine but painful colonoscopy -- but the consequences can be fatal. According to the American Cancer Society, colon cancer is the third most common cancer found in American men and women and kills about 50,000 Americans every year.

"85% of those who develop colon cancer have no symptoms or family history," says Prof. Nadir Arber, a professor of medicine and gastroenterology, at Tel Aviv University's Sackler Faculty of Medicine. "Generally speaking, it's much harder to get these people to comply with taking the test."

To convince more people to undergo the potentially life-saving colonoscopy, Prof. Arber has developed a simple early-warning test that can detect colon cancer in the blood. Using biomarkers, it is the first test on the market that can detect cells of colon polyps –– the precursors to colon cancer –– in the blood, with a very high degree of sensitivity and accuracy.

This painless, non-invasive and inexpensive test could very well be a breakthrough of the decade.

An Attractive Diagnostic Step

"If we can identify those who are prone to cancer through a less invasive test, we can convince them to do the colonoscopy," leading to earlier detection and treatment, says Prof. Arber, who heads the Integrated Cancer Prevention Center at the Tel Aviv Souraski Medical Center.

Now being prepared for the market by Bio Mark Ltd., a subsidiary of Micromedic Technologies Ltd., Prof. Arber's "CD24" test could begin to save thousands of Americans' lives by as early as 2010. With the test, doctors can catch polyp growth in the colon in 80% of patients.

The American Cancer Society suggests that all Americans over the age of 50 receive periodic colonoscopies. With Prof. Arber's test, doctors will be able to screen patients for colon cancer quickly and easily as part of a routine blood test. While not 100% accurate, it will provide a convincing argument for patients to undergo the colonoscopy, and then polyp removal, if necessary.

The novel invention is based on testing CD24, the oncogene for colorectal cancer. It utilizes the fact that polyps in the colon emit biomarkers, which can be detected in the blood at very low levels. Recent studies show that the test can correctly identify adenomas, the polyps that convert to colon cancer, at a success rate of more than 80%.

Some patients forego colonoscopy not just out of fear or distaste, but due to its high cost. Here, too, the breakthrough is significant. While traditional colonoscopies cost about about $1,500 per test, Prof. Arber's procedure is expected to cost much less ― $50 to $100 per test.

Prevention Is Still the Best Medicine

Prof. Arber recommends a number of preventative steps against colon cancer, especially by those at risk. "There are some lifestyle choices people can make to prevent malignancies," he says. "Eating well, exercise, and avoiding smoking and drinking are very important."

Prof. Arber is also working on a drug that prevents the growth of polyps in the colon.

Source: American Friends of Tel Aviv University

Explore further: Team identifies source of most cases of invasive bladder cancer

add to favorites email to friend print save as pdf

Related Stories

Sponge bacteria, a chemical factory

Jan 29, 2014

Sponges are unique beings: they are invertebrates that live in symbiosis with sometimes hundreds of different types of bacteria; similar to lichens which are a biocoenosis of algae and fungi. "Put simply, ...

Toward a urine test for detecting colon cancer

Apr 21, 2010

Scientists are reporting an advance toward development of a urine test for detecting colon cancer, the third most common cancer in the United States. Such a test could eventually compliment or even reduce ...

Test may help predict colon cancer recurrence risk

May 14, 2009

A new gene test may help predict which colon cancer patients are at higher or lower risk of having their cancer return after surgery, doctors report, but whether it is useful enough to justify its likely high price remains ...

Recommended for you

Cancer stem cells linked to drug resistance

3 hours ago

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Unraveling the 'black ribbon' around lung cancer

Apr 17, 2014

It's not uncommon these days to find a colored ribbon representing a disease. A pink ribbon is well known to signify breast cancer. But what color ribbon does one think of with lung cancer?

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

tkjtkj
not rated yet Nov 21, 2008
"People are often reluctant to undergo a routine but painful colonoscopy --"

Sorry, but there is hardly ever
a case where a colonoscopy patient
who has received sedative
anesthesia feels that the procedure
was too uncomfortable. Most have
not even a recollection of it.

More news stories

Low tolerance for pain? The reason may be in your genes

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

How to keep your fitness goals on track

(HealthDay)—The New Year's resolutions many made to get fit have stalled by now. And one expert thinks that's because many people set their goals too high.

Cancer stem cells linked to drug resistance

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

Making graphene in your kitchen

Graphene has been touted as a wonder material—the world's thinnest substance, but super-strong. Now scientists say it is so easy to make you could produce some in your kitchen.

Easter morning delivery for space station

Space station astronauts got a special Easter treat: a cargo ship full of supplies. The shipment arrived Sunday morning via the SpaceX company's Dragon cargo capsule.